JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4526
Amtech Systems
ASYS
$315M
| $5K | ﹤0.01% |
620
+120
| +24% | +$878 |
2017 Q1
1 quarter
|
|
4527
Clarus
CLAR
$132M
| $5K | ﹤0.01% |
800
-6,795
| -89% | -$39.9K |
2017 Q1
1 quarter
|
|
4528
iShares MSCI Israel ETF
EIS
$888M
| $5K | ﹤0.01% |
100
| – | – |
2016 Q4
2 quarters
|
|
4529
iShares Morningstar Multi-Asset Income ETF
IYLD
$124M
| $5K | ﹤0.01% |
200
| – | – |
2016 Q2
4 quarters
|
|
|
SIFY
4530
Sify Technologies
SIFY
$964M
| $5K | ﹤0.01% |
1,165
-218
| -16% | -$1.09K |
2015 Q4
6 quarters
|
|
4531
Spyre Therapeutics
SYRE
$8.22B
| $5K | ﹤0.01% |
+51
| New | +$7.05K |
2017 Q2
0 quarters
|
|
4532
Invesco Solar ETF
TAN
$903M
| $5K | ﹤0.01% |
+250
| New | +$4.54K |
2017 Q2
0 quarters
|
|
4533
iShares Treasury Floating Rate Bond ETF
TFLO
$6.88B
| $5K | ﹤0.01% |
100
| – | – |
2016 Q3
3 quarters
|
|
4534
Tilly's
TLYS
$140M
| $5K | ﹤0.01% |
538
-15,710
| -97% | -$149K |
2015 Q1
9 quarters
|
|
|
UBFO
4535
DELISTED
United Security Bancshares
UBFO
| $5K | ﹤0.01% |
+504
| New | +$4.42K |
2017 Q2
0 quarters
|
|
4536
Unity Bancorp
UNTY
$556M
| $5K | ﹤0.01% |
299
-5,040
| -94% | -$82.9K |
2016 Q4
2 quarters
|
|
4537
Vicor
VICR
$14.2B
| $5K | ﹤0.01% |
302
-10,100
| -97% | -$180K |
2016 Q1
5 quarters
|
|
|
ICD
4538
DELISTED
Independence Contract Drilling, Inc.
ICD
| $5K | ﹤0.01% |
65
-921
| -93% | -$80.4K |
2016 Q4
2 quarters
|
|
|
IMGN
4539
DELISTED
Immunogen Inc
IMGN
| $5K | ﹤0.01% |
683
-186,547
| -100% | -$854K |
2016 Q4
2 quarters
|
|
|
TRCB
4540
DELISTED
Two River Bancorp
TRCB
| $5K | ﹤0.01% |
+279
| New | +$4.93K |
2017 Q2
0 quarters
|
|
|
PZE
4541
DELISTED
Petrobras Argentina S A
PZE
| $5K | ﹤0.01% |
444
| – | – |
2015 Q1
9 quarters
|
|
|
CASC
4542
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $5K | ﹤0.01% |
1,330
-11,253
| -89% | -$44.6K |
2017 Q1
1 quarter
|
|
|
ASBB
4543
DELISTED
ASB Bancorp Inc
ASBB
| $5K | ﹤0.01% |
+109
| New | +$4.4K |
2017 Q2
0 quarters
|
|
4544
American Superconductor
AMSC
$1.45B
| $4K | ﹤0.01% |
1,023
-7,394
| -88% | -$37.6K |
2015 Q4
6 quarters
|
|
|
CMCM
4545
Cheetah Mobile
CMCM
$83.8M
| $4K | ﹤0.01% |
+66
| New | +$3.64K |
2017 Q2
0 quarters
|
|
4546
Diana Shipping
DSX
$356M
| $4K | ﹤0.01% |
1,287
+1,144
| +800% | +$3.33K |
2016 Q4
2 quarters
|
|
4547
Editas Medicine
EDIT
$402M
| $4K | ﹤0.01% |
250
| – | – |
2017 Q1
1 quarter
|
|
4548
First Guaranty Bancshares
FGBI
$137M
| $4K | ﹤0.01% |
+202
| New | +$3.87K |
2017 Q2
0 quarters
|
|
4549
Frontline
FRO
$11.7B
| $4K | ﹤0.01% |
647
+57
| +10% | +$350 |
2013 Q2
16 quarters
|
|
4550
Immunic
IMUX
$109M
| $4K | ﹤0.01% |
3
-54
| -95% | -$72.1K |
2016 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.